Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents

• US 9,862,984 B2
• Filed: 04/23/2007
• Issued: 01/09/2018
• Est. Priority Date: 04/21/2006
• Status: Active Grant

• Current Assignee: Nanobiosym, Inc.
• Original Assignee: Nanobiosym, Inc.
• Inventors: Goel, Anita
• Primary Examiner(s): Hutson, Richard G
• Application Number:
  US11/790,071
• Publication Number:
  US 20070254279A1
• Time in Patent Office: 3,914 Days
• Field of Search: None
• CPC Class Codes: C12Q 1/00 Measuring or testing processes involving enzymes, nucleic acids or microorganisms measuring or testing apparatus with condition measuring or sensing means, e.g. colony counters, C12M1/34; Compositions therefor; Processes of preparing such compositions
• CPC Class Codes: C12Q 1/48 involving transferase
• CPC Class Codes: G01N 2333/16 HIV-1, HIV-2
• CPC Class Codes: G01N 2333/91245 Nucleotidyltransferases (2.7.7)
• CPC Class Codes: G01N 2500/02 Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Abstract

The present application discloses methods and apparatuses for single molecule drug screening, discovery and validation. These methods and apparatuses allow a user to detect rapidly, using observation of single molecules, whether and how a drug candidate interferes with a target enzyme involved in a particular disease pathway. The methods and apparatuses described herein utilize single molecule manipulation and detection technologies (e.g., optical or magnetic tweezers) to directly detect whether the characteristic dynamics, or “mechanical signature,” of the target enzyme-substrate interaction are substantially altered or modulated by a drug candidate. Furthermore, the methods and apparatuses are useful for analyzing the modulation of the mechanical signature in order to identify potential interference mechanisms of a drug candidate. In one aspect of the invention, the methods and apparatuses disclosed herein relate to monitoring the real-time dynamic mechanical signatures of individual polymerase molecules (e.g. DNA polymerases, RNA polymerases, and reverse transcriptases) along a polynucleotide substrate in the presence of drug candidates that either inhibit or otherwise modulate the polymerization process. Identification and analysis of such drug candidates is critical for anti-viral, anti-cancer, and antibiotic drug development.

Claims

1. A method of identifying one or more nucleic acid polymerization modifying drug candidates that affect a nucleic acid polymerase, wherein the method comprises:

contacting a target nucleic acid polymerase with an immobilized substrate of the target polymerase in the absence of one or more nucleic acid polymerization modifying drug candidates, said immobilized substrate being maintained under constant tension by at least partial stretching of the immobilized substrate using feedback control;

detecting and recording with instrumentation a baseline feedback response signal of the applied force necessary to maintain the tension on the immobilized substrate of the target polymerase in the presence of the target polymerase, the baseline feedback response signal being correlated with the velocity of the target polymerase along the bound substrate of the target polymerase, but in the absence of one or more nucleic acid polymerization modifying drug candidates and recording the baseline feedback response signal;

contacting the target polymerase and the substrate of the target polymerase with a nucleic acid polymerization modifying drug candidate; and

detecting and recording with instrumentation a feedback response signal of the applied force necessary to maintain the tension on the immobilized substrate of the target polymerase and further in the presence of the one or more nucleic acid polymerization modifying drug candidates, the feedback response signal being correlated with the velocity of the target polymerase along the bound substrate of the target polymerase in the presence of the one or more nucleic acid polymerization modifying drug candidates and recording the feedback measurement response signal.

2. The method of claim 1, wherein the constant tension using feedback control utilizes at least one of magnetic trapping, optical trapping, and atomic force microscopy.

3. The method of claim 1, wherein the polymerase is selected from the group consisting of:

a DNA polymerase, an RNA polymerase, and a reverse transcriptase.

4. The method of claim 3, wherein the polymerase is a DNA polymerase or an RNA polymerase, and the DNA polymerase or RNA polymerase is a human polymerase.

5. The method of claim 3, wherein the polymerase or reverse transcriptase is a viral polymerase.

6. The method of claim 5, wherein the viral polymerase is a viral reverse transcriptase.

7. The method of claim 6, wherein the viral reverse transcriptase is an HIV-1 reverse transcriptase.

8. The method of claim 3, wherein the polymerase is a bacterial polymerase.

9. The method of claim 1, wherein the substrate of the target polymerase is a polynucleotide, and further detecting and recording time-dependent change in the length of the polynucleotide substrate caused by polymerization.

10. The method of claim 9, wherein the measurement of the time dependent change in length is made using constant tension using feedback control that utilizes at least one of magnetic, and optical trapping.

11. The method of claim 9, further comprising correlating the changes in at least one of the elasticity and the deformation of the substrate of the target polymerase with variations in polymerization time of the substrate of the target polymerase by the target polymerase.

12. The method of claim 9, wherein the one or more nucleic acid polymerization modifying drug candidates is a nucleic acid modifying agent.

13. The method of claim 9, wherein the one or more nucleic acid polymerization modifying drug candidates is a chain-terminating analog of a nucleotide or a nucleoside or a competitive inhibitor of the nucleic acid polymerase.

14. The method of claim 1, wherein the target polymerase is a nucleic acid polymerase, and the substrate of the nucleic acid polymerase is a nucleic acid template, and further wherein the step of determining the mechanical response signal of the nucleic acid polymerase in the presence of the nucleic acid template further includes determining a time-dependent position of the nucleic acid polymerase along its substrate.

15. The method of claim 14, further including real-time tracking of interference between the nucleic acid polymerization modifying drug candidate and the nucleic acid polymerase movement along the nucleic acid template.

16. The method of claim 1, further comprising:

substantially immobilizing a first end of the substrate of the target polymerase;

movably capturing a second end of the substrate of the target polymerase and moving the second end with respect to the first end and maintaining using feedback control a substantially constant force on the second end while the substrate of the target polymerase shortens as a result of polymerization by the target polymerase; and

recording instrumentally a plurality of instantaneous positions of the second end of the substrate of the target polymerase with respect to the first end over one or more polymerization time intervals.